sulpiride has been researched along with Depressive Disorder in 53 studies
Sulpiride: A dopamine D2-receptor antagonist. It has been used therapeutically as an antidepressant, antipsychotic, and as a digestive aid. (From Merck Index, 11th ed)
sulpiride : A member of the class of benzamides obtained from formal condensation between the carboxy group of 2-methoxy-5-sulfamoylbenzoic acid and the primary amino group of (1-ethylpyrrolidin-2-yl)methylamine.
Depressive Disorder: An affective disorder manifested by either a dysphoric mood or loss of interest or pleasure in usual activities. The mood disturbance is prominent and relatively persistent.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To compare the efficacy and safety of amisulpride and olanzapine in subjects with schizophrenia and comorbid depression in a randomised double-blind trial." | 9.12 | A double-blind randomised comparative trial of amisulpride versus olanzapine for 2 months in the treatment of subjects with schizophrenia and comorbid depression. ( Douki, S; Vanelle, JM, 2006) |
| "To determine the effectiveness of amisulpride on depression in patients with schizophrenia, in comparison to risperidone." | 9.12 | Amisulpride versus risperidone in the treatment of depression in patients with schizophrenia: a randomized, open-label, controlled trial. ( Hwang, MY; Kim, JM; Kim, SW; Lee, JH; Lee, SH; Shin, IS; Yang, SJ; Yoon, BH; Yoon, JS, 2007) |
| " In a multicentre, 6 months, placebo-controlled trial, amisulpride (50 mg/daily) was compared to imipramine (100 mg/daily) in the treatment of patients with DSM-III-R criteria for primary dysthymia, dysthymia with major depression or major depression in partial remission." | 9.08 | Amisulpride versus imipramine and placebo in dysthymia and major depression. Amisulpride Study Group. ( Boyer, P; Lecrubier, Y; Rein, W; Turjanski, S, 1997) |
| " However, being a P-glycoprotein efflux substrate with a limited oral bioavailability imposes a challenge to its clinical efficacy." | 5.62 | Hybrid lipid core chitosan-TPGS shell nanocomposites as a promising integrated nanoplatform for enhanced oral delivery of sulpiride in depressive disorder therapy. ( Abdelmonsif, DA; Aly, RG; Elgindy, NA; Mohyeldin, SM; Ragab, D; Samy, WM, 2021) |
| "To compare the efficacy and safety of amisulpride and olanzapine in subjects with schizophrenia and comorbid depression in a randomised double-blind trial." | 5.12 | A double-blind randomised comparative trial of amisulpride versus olanzapine for 2 months in the treatment of subjects with schizophrenia and comorbid depression. ( Douki, S; Vanelle, JM, 2006) |
| "To determine the effectiveness of amisulpride on depression in patients with schizophrenia, in comparison to risperidone." | 5.12 | Amisulpride versus risperidone in the treatment of depression in patients with schizophrenia: a randomized, open-label, controlled trial. ( Hwang, MY; Kim, JM; Kim, SW; Lee, JH; Lee, SH; Shin, IS; Yang, SJ; Yoon, BH; Yoon, JS, 2007) |
| " In a multicentre, 6 months, placebo-controlled trial, amisulpride (50 mg/daily) was compared to imipramine (100 mg/daily) in the treatment of patients with DSM-III-R criteria for primary dysthymia, dysthymia with major depression or major depression in partial remission." | 5.08 | Amisulpride versus imipramine and placebo in dysthymia and major depression. Amisulpride Study Group. ( Boyer, P; Lecrubier, Y; Rein, W; Turjanski, S, 1997) |
| "The effects of once a day dose of sulpiride efficacy and safety was evaluated in patients with major depressive disorder." | 3.69 | Therapeutic effects and side effects in patients with major depression treated with sulpiride once a day. ( Asakura, M; Hasegawa, K; Satoh, Y; Shinozuka, T; Tsukamoto, T; Tsuneizumi, T, 1994) |
| " In an open pilot study, we investigated 26 inpatients (13 female, 13 male) with schizophrenic or depressive disorder treated with SULP (mean daily dosage 64-1062 mg) administered orally, either as a monotherapy or as an add-on treatment to a stable and unchanged medication for 3-60 days." | 2.70 | Serum levels of sulpiride enantiomers after oral treatment with racemic sulpiride in psychiatric patients: a pilot study. ( Härtter, S; Hiemke, C; Köhler, D; Müller, MJ, 2001) |
| " The tolerability evaluation was based on incidence of adverse events and routine laboratory tests." | 2.70 | Efficacy and safety of amisulpride 50 mg versus paroxetine 20 mg in major depression: a randomized, double-blind, parallel group study. ( Cassano, GB; Jori, MC, 2002) |
| " The present data allows the conclusion that (A) low dosed sulpiride seems to act as an antidepressant in severe and milder forms of depression, (B) a clinical progress is seen earlier than is common during treatment with tricyclics and (C) a significant increase of drive is observable." | 2.65 | Effect of sulpiride in endogenous depression. ( Benkert, O; Holsboer, F, 1984) |
| "L-Sulpiride is a dopamine (DA)-receptor blocker that acts as an antidepressant at low doses." | 2.38 | Possible mechanism of antidepressant effect of L-sulpiride. ( Collu, M; D'Aquila, PS; Forgione, A; Fratta, W; Gessa, GL; Serra, G, 1990) |
| " However, being a P-glycoprotein efflux substrate with a limited oral bioavailability imposes a challenge to its clinical efficacy." | 1.62 | Hybrid lipid core chitosan-TPGS shell nanocomposites as a promising integrated nanoplatform for enhanced oral delivery of sulpiride in depressive disorder therapy. ( Abdelmonsif, DA; Aly, RG; Elgindy, NA; Mohyeldin, SM; Ragab, D; Samy, WM, 2021) |
| "The main objective was to identify the occurrence of adverse events associated with amisulpride when combined with antidepressants (ADs)." | 1.37 | Safety of amisulpride in combination with antidepressants under common clinical practice conditions. ( Ceskova, E; Priborska, Z; Suchopar, J, 2011) |
| "One patient died of pulmonary edema and subsequent heart failure, but the rest of the patients recovered without any sequelae." | 1.34 | Hemoperfusion in the treatment of acute clozapine intoxication in China. ( Cai, ZJ; He, JL; Li, WB; Ungvari, GS; Xiang, YT, 2007) |
| "We report on a case of a patient with paranoid schizophrenia, who still presented negative and depressive symptoms during treatment with amisulpride for more than 6 weeks." | 1.33 | Pergolide as adjuvant therapy to amisulpride in the treatment of negative and depressive symptoms in schizophrenia. ( Burlon, M; Göhring, K; Gruschka, P; Kaiser, S; Pfüller, U; Roesch-Ely, D; Weisbrod, M, 2006) |
| "Sulpiride isomers were studied in the rat in four behavioural models of depression which are thought to be influenced by neuroleptics in different ways." | 1.27 | Antidepressant versus neuroleptic activities of sulpiride isomers on four animal models of depression. ( Dall'Olio, R; Gaggi, R; Gandolfi, O; Montanaro, N; Vaccheri, A, 1984) |
| " With a daily dosage of 150 mg, a satisfactory response was recorded in overall pathology in 76." | 1.27 | [Sulpiride and depression]. ( Lestynek, JL, 1983) |
| "Sulpiride was administered intravenously to 19 patients in a depressive or hallucinatory-paranoid state." | 1.27 | Intravenous administration of sulpiride and heat sensation on the body surface. ( Hosaka, H; Kaneko, Y; Yamamoto, Y, 1983) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 12 (22.64) | 18.7374 |
| 1990's | 18 (33.96) | 18.2507 |
| 2000's | 13 (24.53) | 29.6817 |
| 2010's | 9 (16.98) | 24.3611 |
| 2020's | 1 (1.89) | 2.80 |
| Authors | Studies |
|---|---|
| Mohyeldin, SM | 1 |
| Samy, WM | 1 |
| Ragab, D | 1 |
| Abdelmonsif, DA | 1 |
| Aly, RG | 1 |
| Elgindy, NA | 1 |
| Suzuki, H | 1 |
| Hibino, H | 1 |
| Inoue, Y | 1 |
| Mikami, K | 1 |
| Ishola, IO | 1 |
| Awodele, O | 1 |
| Eluogu, CO | 1 |
| Taoka, H | 1 |
| Hamamura, T | 1 |
| Endo, S | 1 |
| Miyata, S | 1 |
| Toma, K | 1 |
| Ishihara, T | 1 |
| Kuroda, S | 1 |
| Hwang, SS | 1 |
| Jung, DC | 1 |
| Ahn, YM | 1 |
| Kim, SH | 1 |
| Kim, YS | 1 |
| Morganstern, I | 1 |
| Tejani-Butt, S | 1 |
| Ilett, KF | 1 |
| Watt, F | 1 |
| Hackett, LP | 1 |
| Kohan, R | 1 |
| Teoh, S | 1 |
| Ružić, K | 1 |
| Grahovac, T | 1 |
| Graovac, M | 1 |
| Dadić-Hero, E | 1 |
| Sepić-Grahovac, D | 1 |
| Sabljić, V | 1 |
| Novak, MR | 1 |
| Ceskova, E | 1 |
| Suchopar, J | 1 |
| Priborska, Z | 1 |
| D'iakonov, AL | 1 |
| Lobanova, IV | 1 |
| Shiraishi, H | 1 |
| Ito, M | 1 |
| Hayashi, H | 1 |
| Otani, K | 1 |
| Kotler, M | 1 |
| Strous, RD | 1 |
| Reznik, I | 1 |
| Shwartz, S | 1 |
| Weizman, A | 1 |
| Spivak, B | 1 |
| Racagni, G | 1 |
| Canonico, PL | 1 |
| Ravizza, L | 1 |
| Pani, L | 1 |
| Amore, M | 2 |
| Kopecek, M | 1 |
| Bares, M | 1 |
| Horácek, J | 1 |
| Roesch-Ely, D | 1 |
| Göhring, K | 1 |
| Gruschka, P | 1 |
| Kaiser, S | 1 |
| Pfüller, U | 1 |
| Burlon, M | 1 |
| Weisbrod, M | 1 |
| Vanelle, JM | 1 |
| Douki, S | 1 |
| Kim, SW | 1 |
| Shin, IS | 1 |
| Kim, JM | 1 |
| Lee, SH | 1 |
| Lee, JH | 1 |
| Yoon, BH | 1 |
| Yang, SJ | 1 |
| Hwang, MY | 1 |
| Yoon, JS | 1 |
| He, JL | 1 |
| Xiang, YT | 1 |
| Li, WB | 1 |
| Cai, ZJ | 1 |
| Ungvari, GS | 1 |
| Iovchuk, NM | 1 |
| Kozlova, IA | 1 |
| Borsini, F | 1 |
| Nowakowska, E | 1 |
| Samanin, R | 1 |
| Vaccheri, A | 1 |
| Dall'Olio, R | 1 |
| Gaggi, R | 1 |
| Gandolfi, O | 1 |
| Montanaro, N | 1 |
| Lestynek, JL | 1 |
| Benkert, O | 2 |
| Holsboer, F | 1 |
| Jaques, R | 1 |
| Kaneko, Y | 2 |
| Yamamoto, Y | 2 |
| Hosaka, H | 1 |
| Mucci, A | 1 |
| Nolfe, G | 1 |
| Maj, M | 1 |
| Maier, W | 1 |
| Sato, T | 1 |
| Sakado, K | 1 |
| Sato, S | 1 |
| León, CA | 1 |
| Vigoya, J | 1 |
| Conde, S | 1 |
| Campo, G | 1 |
| Castrillón, E | 1 |
| León, A | 1 |
| Tsukamoto, T | 1 |
| Asakura, M | 1 |
| Tsuneizumi, T | 1 |
| Satoh, Y | 1 |
| Shinozuka, T | 1 |
| Hasegawa, K | 1 |
| Kato, K | 1 |
| Ebert, D | 1 |
| Feistel, H | 1 |
| Barocka, A | 1 |
| Kaschka, W | 1 |
| Mokrusch, T | 1 |
| Schirmer, G | 1 |
| Nisijima, K | 1 |
| Oyafuso, K | 1 |
| Shimada, T | 1 |
| Hosino, H | 1 |
| Ishiguro, T | 1 |
| Okada, F | 1 |
| Sarfraz, A | 1 |
| Cook, M | 1 |
| Benazzi, F | 2 |
| Lecrubier, Y | 1 |
| Boyer, P | 1 |
| Turjanski, S | 1 |
| Rein, W | 1 |
| Rüther, E | 1 |
| Degner, D | 1 |
| Munzel, U | 1 |
| Brunner, E | 1 |
| Lenhard, G | 1 |
| Biehl, J | 1 |
| Vögtle-Junkert, U | 1 |
| Müller, MJ | 1 |
| Härtter, S | 1 |
| Köhler, D | 1 |
| Hiemke, C | 1 |
| Jori, MC | 2 |
| Cassano, GB | 1 |
| Roś, LT | 1 |
| Sampson, D | 1 |
| Willner, P | 1 |
| Muscat, R | 1 |
| Kaiya, H | 1 |
| Takeda, N | 1 |
| Serra, G | 1 |
| Forgione, A | 1 |
| D'Aquila, PS | 1 |
| Collu, M | 1 |
| Fratta, W | 1 |
| Gessa, GL | 1 |
| Abe, K | 1 |
| Oota, M | 1 |
| Fava, GA | 1 |
| Grandi, S | 1 |
| Saviotti, FM | 1 |
| Conti, S | 1 |
| Bartolucci, G | 1 |
| Savron, G | 1 |
| Kashihara, K | 1 |
| Ishida, K | 1 |
| Kitamura, Y | 1 |
| Sakai, M | 1 |
| Nagasaki, T | 1 |
| Nakajima, K | 1 |
| Shima, S | 1 |
4 reviews available for sulpiride and Depressive Disorder
| Article | Year |
|---|---|
Consensus on the use of substituted benzamides in psychiatric patients.
Topics: Amisulpride; Antipsychotic Agents; Benzamides; Depressive Disorder; Humans; Mental Disorders; Schizo | 2004 |
Levosulpiride: a review of its clinical use in psychiatry.
Topics: Administration, Oral; Clinical Trials as Topic; Depressive Disorder; Dopamine Antagonists; Humans; I | 1995 |
[Changes in the endocrine system in the course of sulpiride therapy].
Topics: Antidepressive Agents, Second-Generation; Antipsychotic Agents; Depressive Disorder; Dopamine Antago | 2001 |
Possible mechanism of antidepressant effect of L-sulpiride.
Topics: Depressive Disorder; Humans; Receptors, Dopamine; Sulpiride | 1990 |
12 trials available for sulpiride and Depressive Disorder
| Article | Year |
|---|---|
Sulpiride augmentation of olanzapine in the management of treatment-resistant chronic schizophrenia: evidence for improvement of mood symptomatology.
Topics: Adolescent; Adult; Affect; Antipsychotic Agents; Anxiety; Basal Ganglia Diseases; Benzodiazepines; C | 2004 |
A double-blind randomised comparative trial of amisulpride versus olanzapine for 2 months in the treatment of subjects with schizophrenia and comorbid depression.
Topics: Adult; Amisulpride; Analysis of Variance; Antipsychotic Agents; Benzodiazepines; Comorbidity; Depres | 2006 |
Amisulpride versus risperidone in the treatment of depression in patients with schizophrenia: a randomized, open-label, controlled trial.
Topics: Adolescent; Adult; Amisulpride; Antipsychotic Agents; Depressive Disorder; Electrocardiography; Endp | 2007 |
Effect of sulpiride in endogenous depression.
Topics: Adult; Clinical Trials as Topic; Depressive Disorder; Female; Humans; Male; Middle Aged; Sulpiride; | 1984 |
Treatment of chronic depression with sulpiride: evidence of efficacy in placebo-controlled single case studies.
Topics: Adult; Anxiety; Case-Control Studies; Chronic Disease; Cross-Over Studies; Depressive Disorder; Doub | 1994 |
[Comparison of the effect of amisulpride and viloxazine in the treatment of dysthymia].
Topics: Adolescent; Adult; Age Distribution; Amisulpride; Depressive Disorder; Double-Blind Method; Female; | 1994 |
Response of patients in mixed state of anxiety and depression to low dose sulpiride.
Topics: Adult; Anxiety Disorders; Depressive Disorder; Female; Humans; Male; Sulpiride | 1993 |
Amisulpride versus imipramine and placebo in dysthymia and major depression. Amisulpride Study Group.
Topics: Adult; Aged; Amisulpride; Antidepressive Agents; Antidepressive Agents, Tricyclic; Depression; Depre | 1997 |
Antidepressant action of sulpiride. Results of a placebo-controlled double-blind trial.
Topics: Adult; Aged; Antidepressive Agents, Second-Generation; Depressive Disorder; Dopamine Antagonists; Do | 1999 |
Serum levels of sulpiride enantiomers after oral treatment with racemic sulpiride in psychiatric patients: a pilot study.
Topics: Adult; Antipsychotic Agents; Chromatography, High Pressure Liquid; Depressive Disorder; Female; Huma | 2001 |
Faster response on amisulpride 50 mg versus sertraline 50-100 mg in patients with dysthymia or double depression: a randomized, double-blind, parallel group study.
Topics: Adolescent; Adult; Aged; Amisulpride; Antidepressive Agents; Antipsychotic Agents; Depressive Disord | 2001 |
Efficacy and safety of amisulpride 50 mg versus paroxetine 20 mg in major depression: a randomized, double-blind, parallel group study.
Topics: Adolescent; Adult; Aged; Amisulpride; Antidepressive Agents, Second-Generation; Antipsychotic Agents | 2002 |
37 other studies available for sulpiride and Depressive Disorder
| Article | Year |
|---|---|
Hybrid lipid core chitosan-TPGS shell nanocomposites as a promising integrated nanoplatform for enhanced oral delivery of sulpiride in depressive disorder therapy.
Topics: Administration, Oral; Caco-2 Cells; Chitosan; Depressive Disorder; Humans; Lipids; Nanocomposites; S | 2021 |
The benefits of the concomitant use of antidepressants and acetyl-l-carnitine in the treatment of moderate depression.
Topics: Acetylcarnitine; Adult; Antidepressive Agents; Citalopram; Depressive Disorder; Drug Therapy, Combin | 2019 |
Potentials of Mangifera indica in the treatment of depressive-anxiety disorders: possible mechanisms of action.
Topics: Animals; Anti-Anxiety Agents; Antidepressive Agents; Anxiety; Anxiety Disorders; Depression; Depress | 2016 |
Antipsychotics possessing antidepressive efficacy increase Golf protein in rat striatum.
Topics: Amisulpride; Animals; Antipsychotic Agents; Benzodiazepines; Blotting, Western; Clozapine; Corpus St | 2008 |
The effects of psychopathology on subjective experience of side effects of antipsychotics in patients with schizophrenia.
Topics: Adult; Amisulpride; Antipsychotic Agents; Anxiety; Benzodiazepines; Cognition Disorders; Depressive | 2010 |
Differential patterns of alcohol consumption and dopamine-2 receptor binding in Wistar-Kyoto and Wistar rats.
Topics: Alcohol Drinking; Animals; Depressive Disorder; Male; Models, Animal; Rats; Rats, Inbred WKY; Rats, | 2010 |
Assessment of infant dose through milk in a lactating woman taking amisulpride and desvenlafaxine for treatment-resistant depression.
Topics: Adult; Amisulpride; Antidepressive Agents; Breast Feeding; Cyclohexanols; Depressive Disorder; Desve | 2010 |
Hyperprolactinaemia with amisulpride.
Topics: Amisulpride; Anti-Anxiety Agents; Antidepressive Agents; Antipsychotic Agents; Anxiety Disorders; Bo | 2011 |
Integrative sulpiride with a homeopathic therapy for treating depressive syndrome--an observational study.
Topics: Adult; Aged; Aged, 80 and over; Antidepressive Agents, Second-Generation; Citric Acid Cycle; Depress | 2011 |
Safety of amisulpride in combination with antidepressants under common clinical practice conditions.
Topics: Adult; Amisulpride; Antidepressive Agents; Depressive Disorder; Drug Therapy, Combination; Female; H | 2011 |
[The comparative study on the efficacy of the combination of serotonin reuptake inhibitor antidepressants and antipsychotics in the treatment of recurrent depressive disorders].
Topics: Adolescent; Adult; Amisulpride; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Benz | 2012 |
Sulpiride treatment of Cotard's syndrome in schizophrenia.
Topics: Adult; Antipsychotic Agents; Delusions; Depressive Disorder; Humans; Male; Schizophrenia; Sulpiride; | 2004 |
Normalization of hyperprolactinaemia after withdrawal of a low dose of amisulpride.
Topics: Adult; Amisulpride; Antipsychotic Agents; Depressive Disorder; Female; Humans; Hyperprolactinemia; M | 2005 |
Pergolide as adjuvant therapy to amisulpride in the treatment of negative and depressive symptoms in schizophrenia.
Topics: Adult; Amisulpride; Antipsychotic Agents; Comorbidity; Depressive Disorder; Dopamine Agonists; Drug | 2006 |
Hemoperfusion in the treatment of acute clozapine intoxication in China.
Topics: Acute Disease; Adult; Alprazolam; Antipsychotic Agents; China; Clonazepam; Clozapine; Depressive Dis | 2007 |
[Results of treating schizophrenic children and adolescents with eglonyl].
Topics: Adolescent; Antidepressive Agents; Antipsychotic Agents; Child; Delusions; Depressive Disorder; Drug | 1982 |
Effect of repeated treatment with desipramine in the behavioral "despair" test in rats: antagonism by "atypical" but not "classical" neuroleptics or antiadrenergic drugs.
Topics: Adrenergic alpha-Antagonists; Animals; Antipsychotic Agents; Butyrophenones; Chlorpromazine; Clonidi | 1984 |
Antidepressant versus neuroleptic activities of sulpiride isomers on four animal models of depression.
Topics: Animals; Antidepressive Agents; Antipsychotic Agents; Apomorphine; Behavior, Animal; Body Temperatur | 1984 |
[Sulpiride and depression].
Topics: Adult; Aged; Ambulatory Care; Depressive Disorder; Female; Humans; Male; Middle Aged; Sulpiride | 1983 |
[Effect of dogmatil on postoperative depression].
Topics: Aged; Depressive Disorder; Female; Humans; Male; Middle Aged; Postoperative Complications; Sulpiride | 1984 |
Intravenous administration of sulpiride and heat sensation on the body surface.
Topics: Adolescent; Adult; Aged; Blood Pressure; Depressive Disorder; Female; Hallucinations; Heart Rate; Hu | 1983 |
Is there any specific personality disorder or personality disorder cluster that worsens the short-term treatment outcome of major depression?
Topics: Adult; Aged; Anti-Anxiety Agents; Antidepressive Agents; Benzodiazepines; Depressive Disorder; Dose- | 1993 |
Therapeutic effects and side effects in patients with major depression treated with sulpiride once a day.
Topics: Depressive Disorder; Humans; Pilot Projects; Psychiatric Status Rating Scales; Sulpiride | 1994 |
A test-retest study of cerebral blood flow during somatosensory stimulation in depressed patients with schizophrenia and major depression.
Topics: Adult; Amitriptyline; Bipolar Disorder; Brain; Brain Mapping; Depressive Disorder; Dominance, Cerebr | 1993 |
[Treatment of depression with a neuro-thymoleptic combination in general practice].
Topics: Ambulatory Care; Amitriptyline; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Depressive D | 1996 |
Cerebrospinal fluid monoamine metabolism in a case of neuroleptic malignant syndrome improved by electroconvulsive therapy.
Topics: Antidepressive Agents; Antipsychotic Agents; Depressive Disorder; Electroconvulsive Therapy; Female; | 1996 |
Why can low doses of sulpiride counteract depression?
Topics: Antidepressive Agents; Antipsychotic Agents; Brain; Depressive Disorder; Dose-Response Relationship, | 1995 |
Sulpiride-induced cholestalic jaundice.
Topics: Aged; Antidepressive Agents, Second-Generation; Chemical and Drug Induced Liver Injury; Cholestasis, | 1996 |
Side-effects of benzamide derivatives.
Topics: Depressive Disorder; Dopamine Antagonists; Female; Humans; Middle Aged; Parkinson Disease, Secondary | 1997 |
Reversal of antidepressant action by dopamine antagonists in an animal model of depression.
Topics: Animals; Antidepressive Agents, Tricyclic; Benzazepines; Depressive Disorder; Disease Models, Animal | 1991 |
Lorazepam, amitriptyline, and sulpiride: withdrawal effects.
Topics: Amitriptyline; Anxiety Disorders; Depressive Disorder; Drug Therapy, Combination; Female; Humans; Lo | 1991 |
Sulpiride in the treatment of delusional depression.
Topics: Adult; Antidepressive Agents; Antipsychotic Agents; Depressive Disorder; Female; Humans; Male; Middl | 1990 |
[Treatment of periodic depressive disorders in adolescents and prevention of recurrence].
Topics: Adolescent; Adult; Age Factors; Depressive Disorder; Female; Humans; Lithium; Male; Periodicity; Pro | 1989 |
Phenomenology and pathophysiology of antipsychotic withdrawal symptoms.
Topics: Adult; Agoraphobia; Anxiety Disorders; Depressive Disorder; Female; Humans; Middle Aged; Substance W | 1989 |
Neuroleptic malignant syndrome due to sulpiride.
Topics: Aged; Depressive Disorder; Female; Humans; Neuroleptic Malignant Syndrome; Sulpiride | 1988 |
Effect of sulpiride on plasma prolactin in healthy volunteers and depressed patients.
Topics: Adult; Depressive Disorder; Female; Humans; Male; Middle Aged; Prolactin; Sex Characteristics; Sulpi | 1986 |
Relationship between plasma level and therapeutic effect of sulpiride.
Topics: Adult; Bipolar Disorder; Depressive Disorder; Dopamine beta-Hydroxylase; Female; Humans; Male; Metho | 1986 |